Show simple item record

dc.contributor.authorDean, JA
dc.contributor.authorWelsh, LC
dc.contributor.authorWong, KH
dc.contributor.authorAleksic, A
dc.contributor.authorDunne, E
dc.contributor.authorIslam, MR
dc.contributor.authorPatel, A
dc.contributor.authorPatel, P
dc.contributor.authorPetkar, I
dc.contributor.authorPhillips, I
dc.contributor.authorSham, J
dc.contributor.authorSchick, U
dc.contributor.authorNewbold, KL
dc.contributor.authorBhide, SA
dc.contributor.authorHarrington, KJ
dc.contributor.authorNutting, CM
dc.contributor.authorGulliford, SL
dc.date.accessioned2017-03-01T12:13:39Z
dc.date.issued2017-04-01
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2017, 29 (4), pp. 263 - 273
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/438
dc.identifier.eissn1433-2981
dc.identifier.doi10.1016/j.clon.2016.12.001
dc.description.abstractAIMS: A normal tissue complication probability (NTCP) model of severe acute mucositis would be highly useful to guide clinical decision making and inform radiotherapy planning. We aimed to improve upon our previous model by using a novel oral mucosal surface organ at risk (OAR) in place of an oral cavity OAR. MATERIALS AND METHODS: Predictive models of severe acute mucositis were generated using radiotherapy dose to the oral cavity OAR or mucosal surface OAR and clinical data. Penalised logistic regression and random forest classification (RFC) models were generated for both OARs and compared. Internal validation was carried out with 100-iteration stratified shuffle split cross-validation, using multiple metrics to assess different aspects of model performance. Associations between treatment covariates and severe mucositis were explored using RFC feature importance. RESULTS: Penalised logistic regression and RFC models using the oral cavity OAR performed at least as well as the models using mucosal surface OAR. Associations between dose metrics and severe mucositis were similar between the mucosal surface and oral cavity models. The volumes of oral cavity or mucosal surface receiving intermediate and high doses were most strongly associated with severe mucositis. CONCLUSIONS: The simpler oral cavity OAR should be preferred over the mucosal surface OAR for NTCP modelling of severe mucositis. We recommend minimising the volume of mucosa receiving intermediate and high doses, where possible.
dc.formatPrint-Electronic
dc.format.extent263 - 273
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER SCIENCE LONDON
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectMouth Mucosa
dc.subjectHumans
dc.subjectHead and Neck Neoplasms
dc.subjectRadiotherapy
dc.subjectRadiotherapy Dosage
dc.subjectLogistic Models
dc.subjectProbability
dc.subjectReproducibility of Results
dc.subjectModels, Biological
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectMiddle Aged
dc.subjectMucositis
dc.subjectYoung Adult
dc.titleNormal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.
dc.typeJournal Article
dcterms.dateAccepted2016-11-01
rioxxterms.versionofrecord10.1016/j.clon.2016.12.001
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-04
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))
pubs.issue4
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Horwich)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radiotherapy Physics Modelling
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Horwich)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radiotherapy Physics Modelling
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume29
pubs.embargo.termsNo embargo
icr.researchteamClinical Academic Radiotherapy (Horwich)
icr.researchteamRadiotherapy Physics Modelling
icr.researchteamTargeted Therapy
dc.contributor.icrauthorDean, Jamie
dc.contributor.icrauthorPatel, Priyanka
dc.contributor.icrauthorHarrington, Kevin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0